Thalamic lesions in multiple sclerosis by 7T MRI: Clinical implications and relationship to cortical pathology

Daniel M Harrison1, Jiwon Oh2, Snehashis Roy3

  • 1Department of Neurology, Johns Hopkins University School of Medicine, Johns Hopkins School of Medicine, USA dharri90@jhmi.edu.

Multiple Sclerosis (Houndmills, Basingstoke, England)
|January 14, 2015
PubMed
Abstract

Insights

High-resolution 7-tesla MRI reveals thalamic lesions in multiple sclerosis (MS) patients. These lesions correlate with disability and gray matter pathology, offering a simpler measure of disease burden.

Area of Science:

  • Neuroimaging
  • Neurology
  • Radiology

Background:

  • Gray matter pathology, including the thalamus, significantly contributes to disability in multiple sclerosis (MS).
  • Conventional MRI may not adequately visualize small thalamic lesions, potentially underestimating disease burden.

Purpose of the Study:

  • To utilize the enhanced signal-to-noise ratio of 7-tesla (7T) MRI to visualize thalamic lesions in MS.
  • To correlate thalamic lesion characteristics with clinical disability and cortical lesions.

Main Methods:

  • Acquisition of 7T MRI scans in 34 MS patients and 15 healthy volunteers.
  • Analysis of thalamic lesion number and volume.
  • Correlation with demographic data, clinical disability measures (EDSS score), and cortical lesions.

Main Results:

  • Thalamic lesions were identified in 70.6% (24/34) of MS cases.
  • Two distinct lesion subtypes were observed: discrete ovoid and diffuse periventricular.
  • Thalamic lesion burden correlated with EDSS score and cortical lesion burden, particularly in progressive MS.

Conclusions:

  • 7T MRI effectively identifies thalamic lesions in MS, which are linked to clinical disability and progressive disease.
  • Thalamic lesion burden serves as a valuable indicator of overall gray matter involvement in MS.